We recently described the discovery, genome, clinical features, genotypes and evolution of a novel and global human respiratory virus named human coronavirus HKU1 (HCoV-HKU1) which is not yet culturable. We expressed a C-terminal FLAG-tagged CoV-HKU1 spike (S) protein by the Semliki Forest Virus (SFV) system and investigated its maturation profile. Pulse chase labeling revealed that S-FLAG was expressed as highmannose N-glycans of monomers and trimers. It was predominantly cleaved into subdomains S1 and S2 during maturation. S1 was secreted into the medium. Immunofluorescence analysis visualized S along the secretory pathway from endoplasmic reticulum to plasma membrane. Cleavage of S and release of HCoV-HKU1 S pseudotyped virus were inhibited by furin or furin-like enzyme inhibitors. The cell-based expressed fulllength S-FLAG could be recognized by the convalescent serum obtained from a patient with HCoV-HKU1 pneumonia. The data suggest that the native form of HCoV-HKU1 spike expressed in our system can be used in developing serological diagnostic assay and in understanding the role of S in the viral life cycle.
Introduction
Coronaviruses are enveloped viruses with non-segmented, positive-sense, single-stranded RNA genomes and are divided into 3 distinct groups. Three new types of human coronaviruses (HCoV) have been discovered since the beginning of the millennium. In 2003, the severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) was identified and assigned as a split-off from group II CoV (1, 2) . In 2004, a group I coronavirus, HCoV-NL63, was discovered in a child with bronchiolitis in the Netherlands (3, 4) . In 2005, another new virus was discovered in an adult patient with acute community acquired pneumonia in Hong Kong. This virus was detected by RT-PCR with conserved primer targeted against the pol gene of coronaviruses from the nasopharyngeal aspirate of this patient. Genomic analysis showed that this novel virus is a group II coronavirus, and the virus was named HCoV-HKU1 (5) . Since then, HCoV-HKU1 has been found in many parts of the world and also in other clinical samples in addition to nasopharyngeal specimens (6) . Overall these studies suggested that HCoV-HKU1 accounts for a significant proportion of coronavirus infections in hospitalized patients presenting with acute respiratory syndromes (7) (8) (9) (10) .
Genomic analysis of over 22 strains revealed that HCoV-HKU1 exhibits a characteristic coronavirus group II genomic organization with the following gene order: 59-replicase, S, E, M, N-39, short untranslated regions in both 59 and 39 ends, 59 conserved coronavirus core leader sequence, putative transcription regulatory sequences (TRS) upstream of multiple ORFs, possession of hemagglutinin esterase gene (HE) and a conserved pseudoknot in the 39 untranslated region. In addition, there are at least 3 genotypes with recombination between the different genotypes (11, 12) . Multiple-alignment comparison with other group II coronavirus spike proteins demonstrated that the HCoV-HKU1 spike displays strong similarities to a class I virus fusion protein with a potential cleavage site between residues 760 and 761, which may be processed by a membrane bound, calcium-dependent resident Golgi protease such as furin. Unlike the case of SARS-CoV spike (5, 13) , the cleavage of S into S1 and S2 fragments by furin might be required for infection. Generally, coronavirus infection is mediated solely by S, of which the subdomains (S1, S2) rearrange during docking with the receptor (14) (15) (16) . Despite the high degrees of homology (60% to 61% amino acid identities) of HCoV-HKU1 S protein with other group II CoV S proteins, HCoV-HKU1 virus has not yet been successfully passaged in cell lines. The tissue tropism, receptor usage during viral entry and its viral life cycle remain poorly understood.
In this study, we expressed the HCoV-HKU1 S in the Semliki Forest Virus (SFV) system (17) . The glycosylation status and intracellular distribution of HCoV-HKU1 S were examined. We demonstrated that HKU1 S is a highmannose N-linked glycoprotein with an estimated molecular weight of ;180 kDa. HCoV-HKU1 S interacted with furinlike enzyme(s) in the Golgi complex during trafficking and was expressed on the cell surface with S1 secreted into the external medium. Inhibition of the cleavage process decreased the release of the pseudotyped virus. Our findings may help to assess the role of S implicated in cell entry or release, and the establishment of a diagnostic tool for further study of HCoV-HKU1 infection.
Materials and Methods
Plasmid Construction. Human codon optimized cDNA encoding HCoV-HKU1 S was synthesized by multi-step PCR using overlapping oligonucleotides. This humanized S served as a template for subsequent S fragment amplification. It was then subcloned, with the C-terminal fused in-frame with FLAG sequence, into the BamHI site of pSFV1 vector (kindly provided by Dr. P. Liljestrom), resulting in the pSFV-S-FLAG. BHK-21 cells were transfected with in vitro transcribed capped S-RNA using SpeI linearized pSFV-S-FLAG template (Roche Applied Science, Indianapolis, IN). For production of SFV-carrying S particles, BHK-21 cells were co-transfected with equal amounts of in vitro transcribed capped pSFV1-S-FLAG, pSFV-Helper-S2 and pSFV-C-S219A RNAs (18) . After 24 hours, recombinant SFV particles were centrifuged at 50,400 3 g for 4 hours (Beckman rotor JA-21, Fullerton, CA).
The synthetic spike gene was also used as a PCR template using a forward primer containing the N-terminal signal sequence with the BamHI site and the Kozak sequence 59-CGCGGATCCCACCATGCTGCTGAT-CATCTTCATCCTG and a reverse-primer containing Cterminal cytoplasmic domain with EcoRI 59-CGGAATTCCTAGTCATCATGGGAGGTCTTGAT to generate the full length spike in pcDNA 3.1(þ), pcDNA-S.
Cell Culture. Transfected BHK-21 cells were grown either at 378C (for spike protein expression), or 338C (for in vivo particles packaging), and 5% CO2 in GMEM medium supplemented with 5% fetal calf serum (FCS) (Invitrogen, Carlsbad, CA) 10% tryptose-phosphate broth (Sigma, St. Louis, MO). 293FT (Invitrogen, Carlsbad, CA) was cultured in DMEM containing 10% FCS, 20 mM HEPES.
Spike-FLAG Protein Expression. BHK-21 cells were either transfected with in vitro transcribed capped S-RNA using a SpeI linearized pSFV-S-FLAG template (Roche Applied Science, Indianapolis, IN) (Liljestrom et al., 1991) or S-carrying pSFV particles. Protein expression from BHK-21 cells was studied at different time periods post-transfection or infection.
Mouse Immunization with Recombinant Spike DNA, RNA and Protein. Three 6-8 week-old Balb/c mice were primed by intramuscular injection (i.m.) with 100 lg pcDNA-S plasmid DNA on day 0 followed by intraperitoneal immunization (i.p.) with 25 lg of purified spike-FLAG protein in complete Freund's adjuvant (Sigma, St. Louis, MO) on day 14. A booster dose of 10 lg of spike-FLAG protein in incomplete Freund's adjuvant (Sigma, St. Louis, MO) was given on day 30. Fifty lg in vitro transcribed capped S-FLAG RNA was co-administered during the three courses of immunization to enhance antibody response. Blood was collected on day 56.
Pulse-Chase Assay and Immunoprecipitation. At 12 hours post-transfection, 1 3 10 6 BHK-21 cells were starved at 378C for 30 minutes in methionine-and cysteine-free DMEM (Invitrogen, Carlsbad, CA) and pulselabeled with 150 lCi [ 35 S] labelled cysteine/methionine per ml (Promix, GE Healthcare) at 378C for 10 minutes. Cells were then washed with complete GMEM and replaced by incubation with complete GMEM containing 2% FCS at 378C from 30 minutes to 12 hours chase times.
Reactions were stopped by rinsing cells with chilled PBS. Cells were lysed and vortexed in 13 lysis buffer (1% NP-40, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA) containing 13 protease inhibitors cocktail (Roche Applied Science, Indianapolis, IN) and incubated in ice for 5-10 minutes. Nuclei and cellular debris were pelleted at 16,000 3 g for 20 minutes. Cleared cell lysate and culture medium was incubated overnight with mouse anti-S immune serum (dilution 1:25) and then with protein Gsepharose (GE Healthcare) for 2 hours at 48C.
Immunoprecipitated proteins were mixed with sample loading buffer containing no DTT and separated by Tris acetate 3-8% SDS-PAGE gel (Invitrogen, Carlsbad, CA).
Images were developed on X-ray Hyperfilm using ECL chemiluminescence substrate (GE Healthcare).
Endoglycosidase H (Endo H) Deglysosylation. Immunoprecipitated protein lysate was mixed in 13 glycoprotein denaturing buffer containing 0.5% SDS and 40 mM DTT (New England Biolabs, Ipswich, MA) and boiled at 1008C for 10 minutes. After denaturation, samples were diluted with reaction buffer and incubated with 500 U Endo H (New England Biolabs, Ipswich, MA) for 2 hours at 378C.
Samples were subjected to denaturation prior to Endo H-deglycosylation as described by the supplier (New England BioLabs, Ipswich, MA). Reaction was stopped with a sample loading buffer containing 40 mM DTT and analysed by SDS-PAGE and X-ray autoradiography as described above.
Spike Protein Cleavage Inhibition. S-transfected BHK-21 cells were treated with furin inhibitor peptidyl chloromethylketone (dec-RVKR-cmk; Calbiochem, San Diego, CA), labelled, chased for 1 hour and processed for immunoprecipitation and SDS-PAGE as described above. Furin in different concentrations (25-100 lM) was tested and maintained at the same required concentration in all steps. Non dec-RVKR-cmk treated cells were added with DMSO to a final concentration of 0.5% as control.
Immunofluorescence and Subcellular Localization Analysis. Subconfluent BHK-21 cells were grown on coverslips and infected with SFV particles carrying S-FLAG at a multiplicity of infection (MOI) ¼ 2. Cells were fixed 7 to 20 hours post-infection in PBS containing 4% paraformaldehyde for 15 minutes and quenched in 13 PBS containing 50 mM of NH 4 Cl for 10 minutes at room temperature. Cells were either permeabilized in PBS 0.1% Triton X-100 for 5 minutes for intracellular staining or unpermeabilized for surface staining and blocked for 1 hour at room temperature in PBS containing 10% goat serum. Cells were incubated for 1 hour with primary antibodies in PBS 5% goat serum, washed and stained with fluorescent dye-conjugated secondary antibodies for 30 minutes. Coverslips were then washed and mounted on slides using ProLong Gold antifade reagent (Molecular Probe, Invitrogen, Carlsbad, CA) prior to image capture by laser scanning confocal microscopy with sequential line scanning with 488, 568 and 638 nm lasers to separate fluorescence of dyes and serial sections obtained at 0.5 lM increments (BIORAD Radiance 2100, Hercules, CA).
Antibodies and serum used in IF analysis include mouse anti-HCoV-HKU1-S immune serum (dilution 1:50); goat anti-mouse IgG (HþL) fluorescein isothiocyanate conjugate (dilution 1:100) (Invitrogen, Carlsbad, CA); rabbit polyclonal against pan cadherin and calreticulin (dilution 1:50 and 1:100, respectively) (Abcam); rabbit polyclonal against giantin (dilution 1:750) (Covance, Denver, PA); goat anti-rabbit IgG (HþL) Texas Red conjugate (dilution 1:50) (Abcam, Cambridge, UK).
FACS Analysis (Flow Cytometry). Infected (MOI ¼ 5) and uninfected BHK-21 cells were detached with 5 mM EDTA 24 hours post-infection. After washing with PBS, cells were fixed with 4% of PFA for 5 minutes at 48C. After fixation, cells (3.0 3 10 5 cells per reaction) were either permeabilized or unpermeabilized and stained with serum and conjugate. Surface or intracellular expression of HCoV-HKU1 S was quantified using a flow cytometer (FACSCalibur) and CellQuest software (both from Becton Dickinson, San Diego, CA).
Antibodies and serum used in FACS analysis include anti-HCoV-HKU1-S mouse immune serum (dilution 1:100); serum sample from recovered patient with HCoV-HKU1 infection (dilution 1:50); goat anti-human IgG (HþL) FITC conjugate (dilution 1:200) (Invitrogen, Carlsbad, CA); and FITC-coupled M2 monoclonal antibodies anti-FLAG (dilution 1: 100) (Sigma, St. Louis, MO).
Production of HCoV-HKU1 Pseudotyped Virus With or Without Furin Inhibitor. Lentivirus-based HCoV-HKU1 S-pseudotypes were generated by co-transfection of pcDNA-S in combination with a pHIV backbone plasmid bearing the GFP reporter gene, pNL4-3-GFP (Zhang et al., 2004) using Lipofectamine 2000 agent as suggested by the supplier of 293FT cells.
For studying the effect of furin inhibitor on pseudotyped virus production, dec-RVKR-cmk at various concentrations, 25-100 lM in DMEM was added to complete DMEM medium 6 hours post-transfection. The control without dec-RVKR-cmk treated 293FT was added with DMSO to final 0.5% to monitor for any inhibitory effect of DMSO on viral production as a compound solvent.
Results
Post-Translational Modification of HCoV-HKU1 S Protein by N-Glycosylation. We expressed S in BHK-21cells as a C-terminal FLAG-tagged fusion using the defective Semliki Forest virus system (SFV) (17) . Metabolic labeling and pulse-chase experiments were performed to analyze the maturation profile of S, a protein of 1356 aa residues with 28 potential N-linked glycosylation (18 in S1 ectodomain and 10 in S2 endodomain) sites ( Fig. 1) (5) . Lysate ( Fig. 1A) and medium ( Fig. 1B) were subjected to immunoprecipitation by mouse anti-HCoV-HKU1-S immune serum. Separation of proteins was run under nonreducing conditions in 3-8% SDS-PAGE. For pulse-chase experiments, S-FLAG protein was readily detected with the apparent molecular mass of 180 kDa as early as in 0.5 hour chase ( Fig. 1A) . As shown by its sensitivity to Endo H deglysosylation, the trimmed 150 kDa protein should be Nglycosylated in the ER with high-mannose N-glycans ( Fig.  1A , 0.5 hour of chase). Throughout 0.5 hour to 12 hours post-chase, S remains Endo H sensitive which indicates that uncleaved S had not been converted to complex type Nglycan and had probably remained in the ER compartment (19) . In addition, there is an unidentified protein with apparent size of 110 kDa at 0.5 hour post-chase which is probably a premature non-full length S expressed and captured during early phase of protein synthesis.
S was cleaved into sub-domains S1 (110 kDa) and S2 (71 kDa) at 1 hour post-chase (Fig. 1A) . The glycosylation patterns of S1 and S2 differed from their precursor. The resistance to Endo H by S1 revealed that it had matured as a complex N-linked glycan as it was trafficked along the ER to the Golgi complex and was able to be secreted into the medium at 12 hours post-chase. S2 was revealed as a hybrid typed N-linked glycan containing minor terminal mannose residues susceptible to Endo H deglycosylation, resulting in a slight mobility shift after Endo H treatment, and it was not detected in the medium (Fig. 1B) . The 180 kDa uncleaved spike decreased in intensity at 3 hours post-chase as it was cleaved into S1 and S2, but remained detectable till 12 hours post-chase. These results indicated that a significant portion of HCoV-HKU1 S matured as cleaved forms of S1 and S2.
The monomeric and trimeric form of S (with molecular mass of .500 kDa) can be detected as early as 0.5 hour post-chase ( Fig. 1A) . No dimeric form was observed. The trimeric S dissociated into its constituents when the protein was heat denatured (1008C) in the presence of SDS/DTT prior to Endo H treatment. This indicated that the trimeric structure assembled as (S1-S2) 3 could be heat-dissociated and could not be maintained under reducing electrophoretic running conditions.
Cleavage of HKU1 Spike Is Inhibited by Furin Inhibitor In Vitro. Since the results of time chased immunoprecipitation ( Fig. 1 ) and the prediction by bioinformatic analysis suggested a potential furin cleavage site, we attempted to demonstrate that furin or a furin-like enzyme, inherent in the trans Golgi network (TGN), is the host cell protease responsible for the cleavage of the S protein (20, 21) . Peptidyl chloromethylketone (dec-RVKR-cmk), which was shown to be a specific inhibitor of furin activity in cultured cells (21) (22) (23) , was used in our assays. Our result demonstrated that the cleavage of the spike is mediated by furin-like enzymes ( Fig. 2A) . In addition to the nearly complete inhibition of cleavage into S1 and S2, the furin inhibitor modified the N-linked glycosylation pattern which increased the molecular size of S ( Fig. 2A) and rendered it resistant to Endo H deglycosylation at 3 hours post-chase (Fig. 2B) . These findings suggested that the uncleaved S was able to be transported to the Golgi and acquired complex N-linked glycosylation.
Subcellular Localization of the Human Coronavirus HKU1 Spike. At 7 hours post-infection (p.i.), when SFV-derived protein expression was still weak, S readily showed an ER and Golgi restricted pattern which overlapped with both the ER and Golgi resident protein calreticulin and giantin, respectively, while S protein appeared to be more concentrated in the Golgi region (Fig. 3A, B) . At 12 hours p.i., in addition to its colocalization with ER and Golgi markers, S was abundantly detected in distinct bright vesicles throughout the cytoplasm and transported to the cell surface ( Fig. 3C, D) and notably colocalized with plasma membrane marker, pan cadherin, until 24 hours p.i. (Fig. 3E ). The strong fluorescent signal displayed on the cell surface suggests that the HCoV-HKU1 S is efficiently transported to the cell surface.
FLAG-Tagged HCoV-HKU1 S Is Expressed in Native Form on Cell Surface and Recognized by Convalescent Patient Serum. To ascertain that the recombinant expressed HCoV-HKU1 S acquired the native conformation, we tested if the cell surface expressed S-FLAG can be recognized by the convalescent serum of a HCoV-HKU1 infected patient when compared with neg- ative control using flow cytometry (Fig. 4) . The surface and intracellular recognition signals were scored as geometric mean fluorescence intensity ratio to negative control of 3.21 and 3.73, respectively (Fig. 4A, B) . The negative control serum was confirmed by ELISA against recombinant S and nucleocapsid of HCoV-HKU1 (data not shown). Since the C-terminal tagged FLAG epitopes were only recognized by cytoplasmic staining but not on surface staining by monoclonal anti-FLAG antibody, the finding verifies the correct topological expression of S with the ectodomain exposed on the cell surface (Fig. 4C, D) . Overall these data suggest that the recombinant S expressed under the SFV system in BHK-21 cells acquired a native conformation and orientation which can be recognized by convalescent patient serum.
Concentration Dependent Inhibition of S Cleavage and Release of HCoV-HKU1-S Pseudotyped Virus by Furin Inhibitor, dec-RVKR-cmk. The furin inhibitor inhibited S cleavage and affected the intracellular processing of S (Fig. 2) . The extent of such changes in S maturation status induced by cleavage inhibition was demonstrated in association with viral release using a surrogate, the lentiviral based pseudotyped viral particles bearing HCoV-HKU1 S. The pseudotyped virus was titered by p24 measurement (BioMérieux). S-transfected BHK-21 cells were incubated with various concentrations of dec-RVKR-cmk from 25-100 lM, followed by metabolic labeling and harvested by immunoprecipitation with antispike immune serum. The results showed that dec-RVKRcmk inhibited cleavage of S at 75-100 lM in S-expressed BHK-21 cells (Fig. 5A ). In addition, we observed an inverse relationship between concentrations of dec-RVKR-cmk and viral yield as demonstrated by a 50% reduction at 25 lM of inhibitor and up to 75% reduction at a higher concentration from 50-100 lM in 293FT cells (Fig. 5B ). Although discrepancy in furin inhibitor concentration levels was observed between the two assays, this could be accounted for by the variation of furin expression and sensitivities to the inhibitor between the two cell lines. The residual p24 detected in supernatant with furin inhibitor at 75-100 lM may be due to the presence of self assembled and secreted lentivirus-like particles (VLP) by gag proteins (24) . It is conceivable that furin-mediated cleavage of the spike protein affects viral release (Fig. 5B ).
Discussion
Soon after the discovery of SARS coronavirus, another two novel human coronaviruses named NL63 and HKU1 were found (8, 10, (25) (26) (27) . Within a period of 2 years, HCoV-HKU1 was found to have a wide geographic distribution (8, 9, 28, 29) and shown to be associated mainly with acute respiratory tract diseases. Though most reported cases are mild upper respiratory tract infections, the mortality of those suffering from acute community acquired pneumonia can reach 20%. Due to the difficulty of culturing this new virus, the understanding of its virology and disease pathogenesis is still limited. The S of coronaviruses had been described as the key molecule which mediates virus entry through docking to specific cellular receptors (16, (30) (31) (32) (33) . Moreover, S of SARS-CoV can bind to possible coreceptor(s) such as DC-SIGN on blood circulating dendritic cells which may facilitate viral transmission to target cells (34, 35) . In this report we used Semliki Forest viral vector, a versatile expression system for the expression of many viral envelope proteins in functional studies. The C-terminal FLAG-tagged recombinant S of HCoV-HKU1 was expressed and studied in terms of its biogenesis, subcellular localization, intracellular processing and trafficking (36) (37) (38) (39) (40) . The findings may provide information for the design of diagnostics, antivirals and vaccination.
Our work demonstrates that the HCoV-HKU1 S, when expressed alone as a monomeric form, is an N-linked high mannose glycoprotein with an estimated molecular weight of 180 kDa. Deglycosylation with Endo H trimmed down the protein to its theoretical size of 150 kDa. It was retained in ER until it underwent proteolyic cleavage by inherent trans Golgi proteases, furin-like enzymes to yield the canonical receptor binding S1 (110 kDa) and transmembrane fusion S2 subunits (71 kDa). This finding suggested that HCoV-HKU1 S resembles other class I viral fusion proteins found in orthomyxoviruses, retroviruses and filoviruses and coronaviruses.
Only two oligomeric forms of S, monomeric and trimeric, were observed. This is in general agreement with the trimerization model of coronavirus S (15, 41, 42) . The trimeric structure composed as (S1-S2) 3 was found to be heat labile and dissociable in reducing condition. Further work on heat sensitivity to gradient of reducing conditions may be required to address the cross-linking properties among S1, S2 and S, which constitute the oligomeric structure of S.
When the intracellular processing of S is not interfered with, S is cleaved into subdomains S1 and S2 which are were harvested 20 hours p.i. and detected with patient convalescent sera (green line) and subsequently by goat anti-human IgG-FITC conjugates in both A and B, with and without permeabilization by 0.1% Triton X-100 respectively. As a control, infected cells were stained by mouse anti-FLAG FITC-conjugated monoclonal antibody (red line) which recognized only intracellular expressed spike (permeabilized, D) but not the surface stained S with C-terminal tagged FLAG (non-permeabilized, C). Background signal control was measured against uninfected cells and stained accordingly (violet line, A-D). Negative control was included using SFV-vector infected cells (pink line, non-permeabilized and permeabilized, E and F respectively) and stained with patient sera (green line). generally resistant to Endo H deglycosylation, indicating that both S1 and S2 mature along the secretory pathway with completion of the N-linked glycosylation pattern which differs from their precursor. S1 is eventually secreted into the medium. Thus the cleaved HCoV-HKU1 S may be the predominant and mature form for the normal viral life cycle.
The findings of the intracellular localization of S using immunofluorescent analysis and pulse-chase assay are compatible with each other. We showed that S is present along the secretory pathway from ER to the plasma membrane. The pulse chase experiment combined with Endo H sensitivity assay showed that S acquires N-linked glycosylation as soon as it reaches the ER at 0.5 hour postchase. Uncleaved S remained in the ER compartment till it had undergone proteolytic cleavage into S1 and S2 by Golgi resident furin-like protease from 1-3 hours post-chase. It occurred with the concomitant trimming of terminal mannose residues and the maturation with the addition of complex N-linked oligosaccharides, which rendered the subdomains Endo H resistant after processing through the secretory compartments. Eventually S1 was transported to the cell surface and secreted, and it could be detected in the culture at 24 hours post-transfection. This observation coincided with the immunofluorescence analysis that demonstrated HCoV-HKU1 S exhibiting an early ER-Golgi restricted pattern at 7 hours p.i. At 12 hours p.i., we observed punctately stained S scattered within the cytoplasm although S remained partially colocalized with ER and Golgi markers. At 24 hours p.i., the surface staining of S became prominent and S1 could be immunoprecipitated from cell culture medium in pulse-chase assay. These findings demonstrated that the efficient trafficking and surface expression of recombinant HCoV-HKU1 S encoded in a SFV vector. The results are comparable to those of previous studies on SARS-CoV S (37, 43) or transmissible gastroenteritis virus (TGEV) S using plasmid expression vectors (44) showing the typical properties of coronavirus S-transfected, which the surface expressed S can trigger fusion adjacent cells resulting syncytia formation. Further, our experiments were not hampered by problems arising from protein overexpression leading to saturation of retention machinery (45) .
Coronavirus spike contains multiple conformational epitopes which are major inducers of neutralizing antibodies and essential for receptor binding (46) (47) (48) (49) ; in addition it has the least sequence conservation among coronavirus proteins which renders it a specific target used for serodiagnosis (5, 50, 51) . According to the analysis in Woo's paper (5), HCoV-HKU1 spike scores only 30-32% amino acid homologies with group 1 coronavirus spike including HCoV-229E and NL-63, 33% with SARS-CoV (group 2b), 32% with IBV (group 3) and 60-61% with its same sub-group 2a including HCoV-OC43. HCoV-HKU1 is a newly identified virus, its clinical epidemiology and seroprevalence in our community remains undetermined. Because the virus cannot be cultured, the gold standard using neutralizing antibody response cannot be performed. ELISA assay using this spike protein would be a robust and economical test. The native surface S expressed in BHK-21 cells can be recognized by convalescent patient serum by flow cytometry. Our result indicates that this cell-based S protein expression system can differentiate false positive antibody detected by ELISA assay using the more cross reactive nucleoprotein as antigen (unpublished data), as well as a tool for future study of the interaction between HCoV-HKU1 S and its potential receptor.
The essentiality of proteolytic maturation among group 2 CoV S proteins, which are normally cleaved, is still Figure 5 . A. Inhibition of recombinant spike protein cleavage is concentration-dependent by a furin inhibitor, dec-RVKR-cmk. S-expressed BHK-21 cells were treated with or without dec-RVKR-cmk, metabolically labeled, chased for 1 hour, immunoprecipitated by anti-S serum and electrophoresed as previously described. Furin inhibitor at various concentrations as indicated was added into culture mediums in all steps. B. Release of HKU1 pseudotyped virus is affected by interference of the furin enzymatic processing. 293FT cells were co-transfected with lentiviral vector and HCoV-HKU1-S bearing plasmid. At 6 hours post-transfection, fresh medium containing various concentrations of dec-RVKR-cmk was replaced, pseudotyped virus in supernatant was clarified and titer was tittered by the level of p24 at 48 hours post-transfection. (Þ 180 kDa uncleaved S; & 110 kDa S1; 71 kDa S2; N untransfected BHK-21 cells, immunoprecipitation negative control.) controversial. Taking the well studied MHV as an example, inhibition of furin cleavage generally decreases cell-cell fusion activity but without any notable effect in viral infectivity and pathogenesis (21, (52) (53) (54) . However, exogenous treatment with trypsin enhances MHV infectivity (55) . In our study of HCoV-HKU1 S, we observed that S matures predominantly in cleaved form which is mediated by the furin-like host protease. This was demonstrated by the direct correlation of S cleavage with the titre of pseudotyped viral release which is dependent on the concentration of furin inhibitor. Therefore the inhibition of cleavage is unlikely to be caused by ubiquitous factor. Further study should address whether the overexpression of furin-like enzymes in cell lines might improve the efficiency of viral isolation from clinical specimens.
Taken together, we have expressed a conformational native C-terminal tagged HCoV-HKU1 S and studied its biogenesis, subcellular localization, proteolytic cleavage and intracellular trafficking. The present study established the intrinsic biochemical properties of this structural protein. These findings will have important bearing on future studies in the exploration of virus-host interaction, identification of receptor and development of an antibody detection test which complements the robust ELISA assay in large-scale sero-epidemiological studies.
